Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Novo Holdings A/S, a subsidiary of Novo Nordisk Foundation, becomes interested party in the Tel Aviv Stock Exchange (TASE), holding 8.42% shares


News provided by

The Tel Aviv Stock Exchange Ltd.

07 Nov, 2023, 16:00 IST

Share this article

Share toX

Share this article

Share toX

TEL AVIV, Israel, Nov. 7, 2023 /PRNewswire/ -- The Tel Aviv Stock Exchange Ltd (TASE: TASE) is pleased to announce the receipt, on Nov 02, 2023, of a notification from Novo Holdings A/S (hereafter: "the Interested Party"), a foreign company registered in Denmark, informing the Company that it is now an interested party in the Company, following the purchase in an OTC transaction of 4,312,024 shares for a consideration of NIS 17.3 per share. Subsequent to the aforesaid purchase, the Interested Party holds 7,785,515 shares of the Company, representing approximately 8.42% of the Company's issued share capital and the voting rights therein. Additionally, the Interested Party has informed the Company that it holds a holding permit from the Israel Securities Authority for a holding of up to 10%, subject to the terms set out in said permit.

To complete the picture, it should be noted that the Interested Party is a subsidiary of Novo Nordisk Foundation, a business fund without a controlling shareholder, incorporated in Denmark.

https://maya.tase.co.il/reports/details/1556628

Contact:
Orna Goren
Head of Communication and Public Relations Unit
Tel: +972 76 8160405
[email protected]

SOURCE The Tel Aviv Stock Exchange Ltd.

Modal title

Also from this source

TASE Reports the Results of the Financial Statements for the First Quarter of 2026: The strong financial statements for Q1 2026 reveal record results across all TASE's core business lines and operations

The Tel-Aviv Stock Exchange Ltd. (TASE: TASE) today published its financial results for the first quarter ended March 31, 2026. The quarter was...

TASE Reports the Results of the Financial Statements for the Fourth Quarter and Full Year 2025

The Tel-Aviv Stock Exchange Ltd. (TASE: TASE) today published its financial results for the fourth quarter ended December 31, 2025 and for 2025. For...

More Releases From This Source

Explore

Banking & Financial Services

Banking & Financial Services

New Products & Services

New Products & Services

Accounting News & Issues

Accounting News & Issues

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.